JA OVER SAT - Molecular Random Access Analyzer 4.2.2025 2-BC Signed1_Redacted.pdf

This is a Justification and Approval (J&A) document for a sole-source contract with an Indefinite-Delivery Indefinite-Quantity (IDIQ) award for a Clinical Laboratory Molecular platform. The Department of Veterans Affairs (VA) Caribbean Healthcare System is seeking a Genexpert Infinity 48 testing system capable of performing rapid real-time Polymerase Chain Reaction (PCR) nucleic acid analysis for multiple disease detection, including Mycobacterium tuberculosis, Clostridium difficile, MRSA, SARS-CoV-2, and other pathogens.

The proposed contract will run for five years from 4/19/2025 through 4/18/2030. Market research determined that only one vendor meets all requirements for a fully-integrated, automated testing system with random access capabilities. The system must produce multiple test results simultaneously in two hours or less, operate in manual or automated modes, and provide molecular diagnostic testing for antimicrobial resistance. The total estimated contract value is redacted, with yearly quantities specified for various test types including MRSA, C. Diff, XPRS SARS-CoV-2/FLU/RSV tests, and instrument monthly lease/service payments.